| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human IL-2 concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IL-2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IL-2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IL-2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IL-2. You can calculate the concentration of Human IL-2 in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 4.69 pg/mL |
|---|---|
| Detection Range | 7.81-500 pg/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human IL-2 in samples. No significant cross-reactivity or interference between Human IL-2 and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 4.69 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant IL-2 standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
An Engineered Probiotic Consortium Based on Quorum-Sensing for Colorectal Cancer Immunotherapy (2025) Advanced Science. 10.1002/advs.202512744
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer (2021) Acta Pharmaceutica Sinica B. 10.1016/j.apsb.2021.07.016
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy (2026) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 10.1016/j.ijbiomac.2026.151271
Akkermansia muciniphila-derived outer membrane protein Amuc_1100 promotes acetylation of RING Finger Protein 181 promoter and mediates Autophagy Related 7 ubiquitination to activate CD8+ T cells in lung adenocarcinoma (2025) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 10.1016/j.ijbiomac.2025.147773
DDX3 regulates cancer immune surveillance via 3′ UTR-mediated cell-surface expression of PD-L1 (2024) Cell Reports. 10.1016/j.celrep.2024.113937
MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma (2020) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 10.1186/s13046-020-01752-2
miR-122–5p regulates hepatocytes damage caused by BaP and DBP co-exposure through SOCS1/STAT3 signaling in vitro (2021) ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY. 10.1016/j.ecoenv.2021.112570
Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis (2021) WORLD JOURNAL OF GASTROENTEROLOGY. 10.3748/wjg.v27.i38.6489
Cytokine physiognomies of MSCs from varied sources confirm the regenerative commitment post-coculture with activated neutrophils (2020) JOURNAL OF CELLULAR PHYSIOLOGY. 10.1002/jcp.29713
Phloretin-nanospanlastics for targeting the Akt/PI3K signaling pathways in dimethylhydrazine-induced colon cancer in mice (2024) International Journal of Pharmaceutics-X. 10.1016/j.ijpx.2024.100311
Deubiquitinating Enzyme UCHL1 Modulates FHL2 to Block Ferroptosis and Counteract CD8+ T Cell Anti-Tumour Immunity in Lung Adenocarcinoma (2025) IMMUNOLOGY. 10.1111/imm.70057
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma (2025) Translational Oncology. 10.1016/j.tranon.2025.102381
Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4+ T cells by targeting Myc in patients with dilated cardiomyopathy (2016) JOURNAL OF BIOLOGICAL CHEMISTRY. 10.1074/jbc.M116.765107
Effects of non-surgical periodontal therapy on inflammatory markers of psoriasis: A randomized controlled trial (2019) JOURNAL OF CLINICAL PERIODONTOLOGY. 10.1111/jcpe.13205
SLC7A11-specific CAR-T cell therapy potently targets colorectal and pancreatic cancer (2025) iScience. 10.1016/j.isci.2025.113713
Clonorchis sinensis Co-infection Could Affect the Disease State and Treatment Response of HBV Patients (2016) PLoS Neglected Tropical Diseases. 10.1371/journal.pntd.0004806
Association between serum cytokine levels with pulp necrosis and apical periodontitis in sickle cell disease (2025) Scientific Reports. 10.1038/s41598-025-24851-6
Deletion of Thymic Myoid Cells Regulates the Thymic Microenvironment Involved in the Progression of Tumor-Associated Myasthenia Gravis (2025) CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 10.1093/cei/uxaf043
An ayurvedic approach to immunomodulation employing a green delivery of phytonutrients: A randomized, double-blind, placebo-controlled study on mild allergic rhinitis (2024) Journal of Functional Foods. 10.1016/j.jff.2024.106619
LUCAT1/PTBP1/HIF-1α feedback loop promotes T cell over-differentiation and Th1/Th2-skewed immune imbalance in sepsis via glucose metabolism (2026) CYTOKINE. 10.1016/j.cyto.2026.157157
Mechanism of the Proprietary Chinese Medicine “JiuLiWan” to Treat Ulcerative Colitis Revealed by Network Pharmacology, Molecular Docking, and Experimental Verification In Vitro (2025) ACS Omega. 10.1021/acsomega.5c00261
Impact of intralesional tuberculin PPD injection on anogenital warts: Interferon-α, interleukin-2, and treatment outcomes (2026) Human Vaccines & Immunotherapeutics. 10.1080/21645515.2026.2612814
MiRNA505/NET1 Axis Acts as a CD8+ T-TIL Regulator in Non-Small Cell Lung Cancer (2020) OncoTargets and Therapy. 10.2147/OTT.S265859
ALDOB suppresses the activity of CD8+ T?cells in colorectal cancer via the WNT signaling pathway (2025) IMMUNOLOGY AND CELL BIOLOGY. 10.1111/imcb.12853
Etiology and clinical significance of peripheral blood cytokines in geriatric patients with pulmonary infections (2025) Frontiers in Medicine. 10.3389/fmed.2025.1680586
